PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.94%
Some net income increase while CRWD is negative at -20.26%. John Neff would see a short-term edge over the struggling competitor.
15.72%
D&A growth well above CRWD's 14.90%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-25.15%
Negative yoy deferred tax while CRWD stands at 75.29%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
5.04%
SBC growth well above CRWD's 3.89%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-88.08%
Negative yoy working capital usage while CRWD is 349.19%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
205.97%
AR growth well above CRWD's 152.99%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-778.18%
Negative yoy inventory while CRWD is 100.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-121.79%
Negative yoy AP while CRWD is 101.30%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-173.54%
Both reduce yoy usage, with CRWD at -138.12%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-100.51%
Negative yoy while CRWD is 201.74%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-8.11%
Negative yoy CFO while CRWD is 10.44%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-7.57%
Negative yoy CapEx while CRWD is 18.74%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-37.78%
Both yoy lines negative, with CRWD at -34019.57%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
42.78%
Purchases well above CRWD's 66.84%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
14.64%
Proceeds from sales/maturities above 1.5x CRWD's 7.41%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-139.01%
Both yoy lines negative, with CRWD at -7.03%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-2.38%
Both yoy lines negative, with CRWD at -348.09%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
52.09%
Debt repayment growth of 52.09% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
32.21%
We slightly raise equity while CRWD is negative at -97.54%. John Neff sees competitor possibly preserving share count or buying back shares.
2.45%
We have some buyback growth while CRWD is negative at -100.00%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.